Provided by Tiger Fintech (Singapore) Pte. Ltd.

Equillium Inc.

0.7900
+0.07009.72%
Post-market: 0.79000.00000.00%18:30 EST
Volume:76.14K
Turnover:57.55K
Market Cap:27.99M
PE:-6.04
High:0.7900
Open:0.7215
Low:0.6930
Close:0.7200
Loading ...

EQ Resources Updates Investors Amid Market Uncertainties

TIPRANKS
·
21 Nov 2024

EQ Resources Unveils Strategic Plans in Upcoming Webinar

TIPRANKS
·
19 Nov 2024

EQ Resources Agrees to Acquire Tungsten Metals Group; Shares Hit New 52-Week High

MT Newswires Live
·
18 Nov 2024

EQ Resources to acquire Vietnam’s largest ferrotungsten plant in $13.5m deal

Small Caps
·
18 Nov 2024

EQ Resources Expands with Tungsten Metals Acquisition

TIPRANKS
·
18 Nov 2024

Equillium Q3 EPS $0.00Beats $(0.26) Estimate, Sales $12.16M Miss $15.40M Estimate

Benzinga
·
14 Nov 2024

Equillium Inc -Phase 2 Ulcerative Colitis Study Recently Completed; Topline Data Expected Q1 2025

THOMSON REUTERS
·
14 Nov 2024

Equillium Inc -Believes Its Cash, Cash Equivalents and Short-Term Investments Are Sufficient to Fund Operations Into the Q4 2025

THOMSON REUTERS
·
14 Nov 2024

Equillium Q3 Operating Expenses USD 12.84 Million

THOMSON REUTERS
·
14 Nov 2024

Equillium to Present at the Stifel Healthcare Conference

Business Wire
·
13 Nov 2024

Equillium Announces Poster Presentation at the Society for Immunotherapy of Cancer

Business Wire
·
12 Nov 2024

EQ Resources Secures Key Tungsten Supply Deal

TIPRANKS
·
12 Nov 2024

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
11 Nov 2024

EQ Resources Updates Tungsten Production Data and Expansion Plans

TIPRANKS
·
08 Nov 2024

Equillium, Inc. (EQ) to Report Q3 Results: Wall Street Expects Earnings Growth

Zacks
·
06 Nov 2024

Analysts Have Conflicting Sentiments on These Healthcare Companies: Equillium (EQ), Quest Diagnostics (DGX) and Alnylam Pharma (ALNY)

TIPRANKS
·
05 Nov 2024